Designing devices for inhaled drugs to ensure patient compliance is a priority for device manufacturers. Chemicals Knowledge Hub recently published an article authored by Andreas Meliniotis, Vectura’s Director of Device Development, focused on the opportunity for the development of new, improved devices to ensure inhaled drugs can be accessible for a wide range of patients, which can also treat various diseases and conditions effectively.
Traditional inhalers and nebulizers can be difficult to operate and require the patient to time their inspiration breaths with the drug’s release. Additionally, devices may not be appropriate for all patients, such as paediatrics, or may also be difficult to operate for those with dexterity issues, such as osteoarthritis patients.
Ultimately, it is important to remember the person for whom the device is being created: the patient. A device clearly needs to be robust, and deliver the product. But a design that is not patient-centric is unlikely to succeed.
You can read the full article here.